{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:00:28Z","timestamp":1791838828275,"version":"4.3.4"},"reference-count":180,"publisher":"American Society for Clinical Investigation","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,20]]},"DOI":"10.1172\/jci136094","type":"journal-article","created":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T22:01:28Z","timestamp":1587333688000},"page":"2152-2163","source":"Crossref","is-referenced-by-count":100,"title":["Complementopathies and precision medicine"],"prefix":"10.1172","volume":"130","author":[{"given":"Eleni","family":"Gavriilaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5741-1255","authenticated-orcid":false,"given":"Robert A.","family":"Brodsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1999.tb08532.x"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI126119"},{"issue":"1","key":"B3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1182\/asheducation-2018.1.371","article-title":"Complement-driven anemia: more than just paroxysmal nocturnal hemoglobinuria","volume":"2018","author":"Merrill","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2017.02.003"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2015.02.001"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104053441406"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2008.00350.x"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(79)90089-0"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(82)90116-7"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0162-3109(99)00007-7"},{"issue":"1","key":"B11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4049\/jimmunol.135.1.445","article-title":"The membrane attack complex of complement: relation of C7 to the metastable membrane binding site of the intermediate complex C5b-7","volume":"135","author":"Preissner","year":"1985","journal-title":"J Immunol"},{"key":"B12","article-title":"Local release of properdin in the cellular microenvironment: role in pattern recognition and amplification of the alternative pathway of complement","volume":"3","author":"Cortes","year":"2012","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1983.tb18116.x"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1084\/jem.143.2.241"},{"key":"B15"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.2.688-693.2000"},{"issue":"pt 4","key":"B17","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1099\/0022-1317-81-4-949","article-title":"Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1","volume":"81","author":"Saifuddin","year":"2000","journal-title":"J Gen Virol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202588109"},{"key":"B19"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2019.02.008"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15445"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107525"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5247.348"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0168-x"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2013.04.003"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053019"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1926"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20092301"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1923"},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01590","article-title":"The human platelet as an innate immune cell: interactions between activated platelets and the complement system","volume":"10","author":"Eriksson","year":"2019","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2015.00049","article-title":"Platelets and the complement cascade in atherosclerosis","volume":"6","author":"Patzelt","year":"2015","journal-title":"Front Physiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2015.03.244"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-522128"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-09-311381"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.7.4794"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nri2402"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2008.03.008"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903678"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.03.015"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nm1419"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-412080"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2016.04.008"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900047"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900503"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-882993"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.07.040189.000343"},{"issue":"9","key":"B47","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.4049\/jimmunol.144.9.3478","article-title":"The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9","volume":"144","author":"Rollins","year":"1990","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1172\/JCI101081"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/114.3.459"},{"issue":"4","key":"B50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cyto.b.20525","article-title":"Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry","volume":"78","author":"Borowitz","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04992.x"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511093331904"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061648"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-094136"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-876805"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-876136"},{"issue":"suppl 1","key":"B57","article-title":"One-year efficacy and safety from a phase 3 trial of ravulizumab in adult patients with paroxysmal nocturnal hemoglobinuria receiving prior eculizumab treatment","volume":"134","author":"Kulasekararaj","year":"2019","journal-title":"Blood"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-11-189944"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-732800"},{"issue":"suppl 2","key":"B61","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.cmi.2018.02.002","article-title":"ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)","volume":"24","author":"Winthrop","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4657"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.156"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2018.02.002"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003399"},{"issue":"suppl 1","key":"B66","article-title":"Mechanistic evaluation of efficacy using biomarkers of the oral, small molecule factor d inhibitor, danicopan (ACH-4471), in untreated patients with paroxysmal nocturnal hemoglobinuria (PNH)","volume":"134","author":"Risitano","year":"2019","journal-title":"Blood"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-124748"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.enzmictec.2013.10.007"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-781450"},{"issue":"suppl 1","key":"B70","article-title":"Inhibition of C3 with APL-2 results in normalisation of markers of intravascular and extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH)","volume":"132","author":"Wong","year":"2018","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.091702"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.282.6281.2023"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3597"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-06-856930"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-132490"},{"key":"B76","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00337","article-title":"Complement in thrombotic microangiopathies: unraveling Ariadne\u2019s thread into the labyrinth of complement therapeutics","volume":"10","author":"Gavriilaki","year":"2019","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-015-3076-8"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13571"},{"key":"B79","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.03008","article-title":"Heme drives susceptibility of glomerular endothelium to complement overactivation due to inefficient upregulation of heme oxygenase-1","volume":"9","author":"May","year":"2018","journal-title":"Front Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2015.03.246"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1375296"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810739"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30062-4"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018070759"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2590"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-579953"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012090884"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02210310"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.04.028"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.630871"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-640995"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2015.02.002"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-547067"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018020184"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2018.11.012"},{"issue":"9","key":"B96","first-page":"565","article-title":"Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments","volume":"12","author":"Chapin","year":"2014","journal-title":"Clin Adv Hematol Oncol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-02-629683"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2016.01.005"},{"issue":"6","key":"B99","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99128","article-title":"Germline mutations in the alternative pathway of complement predispose to HELLP syndrome","volume":"3","author":"Vaught","year":"2018","journal-title":"JCI Insight"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.03.003"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-007252"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208981"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003573"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-016-0288-3"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2015.11.026"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.423"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-770214"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2014.01.434"},{"issue":"3","key":"B109","first-page":"310","article-title":"Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome","volume":"10","author":"Macia","year":"2017","journal-title":"Clin Kidney J"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-014-2990-5"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2016.06.002"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701695"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/ng912"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2018.09.002"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfx369"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-013-2503-y"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2019.07.017"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(16)32330-4"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1080\/14767050500072722"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2010.01.021"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-018-0517-z"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2017.39"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02217.x"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-501445"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1692721"},{"key":"B126","article-title":"Pretransplant genetic susceptibility: Clinical relevance in transplant-associated thrombotic microangiopathy","author":"Gavriilaki","journal-title":"Thromb Haemost"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-564997"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.03.032"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.87"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000601"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.08.019"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1182\/blood"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2016002832"},{"key":"B134","unstructured":"Rambaldi A, et al. Improved survival following OMS721 treatment of hematopoieic stem cell transplant-associated thrombotic microangiopathy (HCT-TMA). Paper presented at: 23rd Congress of the European Hematology Association; June 14\u201317, 2018; Stockholm, Sweden. http:\/\/library.ehaweb.org\/eha\/2018\/stockholm\/215162\/alessandro.rambaldi.improved.survival.following.oms721.treatment.of.html Updated June 15, 2018. Accessed March 9, 2020"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204838"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1304718"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1002\/art.21157"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312458839"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1319"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-537704"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1172\/JCI18817"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/nm1121"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-01-070631"},{"issue":"5","key":"B145","first-page":"455","article-title":"Antiphospholipid antibodies and complement activation in patients with cerebral ischemia","volume":"10","author":"Davis","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-08-0554"},{"issue":"6","key":"B147","first-page":"1279","article-title":"Is there an association between complement activation and antiphospholipid antibody-related thrombosis?","volume":"104","author":"Devreese","year":"2010","journal-title":"Thromb Haemost"},{"key":"B148","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00449","article-title":"Complement in the pathophysiology of the antiphospholipid syndrome","volume":"10","author":"Chaturvedi","year":"2019","journal-title":"Front Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003863"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-672139"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1002\/art.34440"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev371"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000290"},{"key":"B154","article-title":"36-year-old female with catastrophic antiphospholipid syndrome treated with eculizumab: a case report and review of literature","volume":"2014","author":"Strakhan","year":"2014","journal-title":"Case Rep Hematol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12540"},{"issue":"5","key":"B156","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis \u2014 autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1987.tb51301.x"},{"issue":"2","key":"B158","first-page":"78","article-title":"Myasthenia gravis: demonstration of membrane attack complex in muscle end-plates","volume":"5","author":"Fazekas","year":"1986","journal-title":"Clin Neuropathol"},{"issue":"1\u20132","key":"B159","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0165-5728(96)00133-6","article-title":"Increased in vitro uptake of the complement C3b in the serum of patients with Guillain-Barr\u00e9 syndrome, myasthenia gravis and dermatomyositis","volume":"71","author":"Basta","year":"1996","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"B160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jneuroim.2004.08.002","article-title":"The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo","volume":"158","author":"Romi","year":"2005","journal-title":"J Neuroimmunol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.7.3847"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2006.03198.x"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1172\/JCI16086"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2006.03205.x"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23448"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09498-4"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30369-1"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-015-0387-9"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a6cb5c"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-312601"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1109980108"},{"issue":"pt 2","key":"B172","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1333-z"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1448-x"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70076-0"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900866"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-1039-7"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.09.044"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2016.03.006"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.37"}],"container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jci.org\/articles\/view\/136094\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T08:24:42Z","timestamp":1722759882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jci.org\/articles\/view\/136094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":180,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,3,23]]},"published-print":{"date-parts":[[2020,3,23]]}},"alternative-id":["10.1172\/JCI136094"],"URL":"https:\/\/doi.org\/10.1172\/jci136094","relation":{},"ISSN":["0021-9738","1558-8238"],"issn-type":[{"value":"0021-9738","type":"print"},{"value":"1558-8238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,20]]}}}